GSA CAPITAL PARTNERS LLP - ADAMAS PHARMACEUTICALS INC ownership

ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 128 filers reported holding ADAMAS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of ADAMAS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$557,000
+451.5%
105,551
+402.3%
0.06%
+270.6%
Q1 2021$101,000
+29.5%
21,013
-31.1%
0.02%
-60.5%
Q2 2020$78,000
-25.7%
30,484
-16.2%
0.04%
+65.4%
Q1 2020$105,000
-58.7%
36,386
-45.6%
0.03%
-13.3%
Q4 2019$254,000
+19.8%
66,913
+716.0%
0.03%
+172.7%
Q2 2018$212,000
-1.4%
8,200
+7.9%
0.01%0.0%
Q4 2015$215,000
-60.3%
7,600
-76.5%
0.01%
-59.3%
Q3 2015$542,000
+12.0%
32,403
+17.2%
0.03%
+42.1%
Q1 2015$484,000
+52.7%
27,654
+51.7%
0.02%
-13.6%
Q4 2014$317,000
+30.5%
18,226
+39.8%
0.02%
+69.2%
Q3 2014$243,00013,0400.01%
Other shareholders

There were no reported owners of ADAMAS PHARMACEUTICALS INC in Q3 2018.

NameSharesValueWeighting ↓
View complete list of ADAMAS PHARMACEUTICALS INC shareholders